Syngene International Ltd Net Profit is INR 101.8 crores in Quarter 3, October – December of Financial Year 2020-2021.
Quarterly Net Earnings Year-on-Year
Syngene International Ltd Quarter Net Profit is Up by 11 % from Last Year Quarter and Net Profit of INR 101.8 crores is reported in Quarter 3, October – December of Financial Year 2020-2021. Last Year Quarter 3, October – December of Financial Year 2019-2020 Net Profit was INR 91.6 crores.
Quarterly Net Sales Year-on-Year
Syngene International Ltd Quarter Sale is up 13 % from Last Quarter. Sales of 584.1 is reported in Quarter 3, October – December of Financial Year 2020-2021. In Last Year Quarter 3, October – December of Financial Year 2019-2020 Sale was 519.1
Annual Sales & Net Earning
Syngene International Ltd Annual Sales in Financial Year 2019 to 2020 was reported INR 1825.6 crores and Annual Profit in Financial Year 2019 to 2020 was reported INR 330.7 crores.
Syngene International Ltd Stock Information
| Sector | Pharmaceuticals |
| Industry | Pharmaceuticals – Indian – Bulk Drugs & Formln |
| About | Syngene International is engaged in providing contract research and manufacturing services from lead generation to clinical supplies to pharmaceutical and biotechnology companies worldwide. Syngenes services include integrated drug discovery and development capabilities in medicinal chemistry, biology, in vivo pharmacology, toxicology, custom synthesis, process R&D, cGMP manufacturing, formulation and analytical development along with Clinical development services. |
| Latest Qaurter EPS | 2.545 |
Syngene International Ltd Stock Analysis:
Get more Quarterly Earnings Results of companies
Get complete data on Syngene International Ltd
